A short exposure to a high-glucose milieu stabilizes the acidic vacuolar apparatus of insulinoma cells in culture to ensuing oxidative stress

APMIS

Volumn 105, Issue 9, 1997, Pages 689-698

  Olejnicka, Beata T ^a   Öllinger, Karin ^a   Brunk, Ulf T ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Autophagocytosis; Insulinoma cells; Iron; Lysosomes; Oxygen radicals

Indexed keywords

ALLOXAN; DEFEROXAMINE;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; INSULINOMA; LYSOSOME; LYSOSOME MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030782935     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05072.x     Document Type: Article

References (52)

1. +, NADPH and nicotinamide on isolated pancreatic rat islets. Biochim. Biophys. Acta 297: 352-367, 1973.
2. Bhattacharya, G.: On the protection against alloxan diabetes by hexoses. Science 120: 841-843, 1953.
3. Borg, H., Eider, S. J., Andersson, A. & Hellerström, C.: Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells. Biochem. J. 182: 797-802, 1979.
4. Brunk, U. T., Jones, C. B. & Sohal, R. S.: A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat. Res. 275: 395-403, 1992.
5. Brunk, U. T., Zhang, H., Dalen, H. & Öllinger, K.: Exposure of cells to nonlethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Radic. Biol. Med. 19: 813-822, 1995.
6. Brunk, U. T., Zhang, H., Roberg, K. & Öllinger, K.: Lethal hydrogen peroxide toxicity involves lysosomal iron-catalyzed reactions with membrane damage. Redox Report 1: 267-277, 1995.
7. Cramer, S. M., Nathanael, B. & Horváth, C.: High-performance liquid chromatography of deferoxamine and ferrioxamine: interference by iron present in the chromatographic system. J. Chromatogr. 31: 345-357, 1984.
8. Deamer, D. W., Heikkila, R. E., Pangamala, R. V., Cohen, G. & Cornwell, D. G.: The alloxan-dialuric acid cycle and the generation of hydrogen peroxide. Physiol. Chem. Phys. 3: 426-430, 1971.
9. Dunford, H. B.: Free radicals in iron-containing systems. Free Radic. Biol. Med. 3: 405-421, 1987.
10. Dunn, J. S., Sheehan, J. L. & McLetchie, N. G. B.: Necrosis of islets of Langerhans produced experimentally. Lancet 1: 484-487, 1943.
11. Fischer, L. J. & Harman, A. W.: Drugs and chemicals that produce diabetes. Trends Pharmacol. Sci. 6: 72-75, 1985.
12. Gower, J., Healing, G. & Green, C.: Measurement by HPLC of desferrioxamine-available iron in rabbit kidneys to assess the effect of ischaemia on the distribution of iron within the total pool. Free Radic. Res. Comm. 5: 291-299, 1989.
13. Grankvist, K., Marklund, S. L. & Täljedal, I.-B.: CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199: 393-398, 1981.
14. Hamaguchi, K., Gaskins, H. R. & Leiter, E. H.: NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849, 1991.
15. Heikkila, R. E., Winston, B., Cohen, G. & Barden, H.: Alloxan-induced diabetes - evidence for hydroxyl radical as a cytotoxic intermediate. Biochem. Pharmacol. 25: 1085-1092, 1976.
16. Houée-Levin, C., Gardés-Albert, M., Ferradini, C. & Pucheault, J.: Pulse radiolytic investigations of the redox system alloxan-dialuric acid: evidence for a radical intermediate. Biochem. Biophys. Res. Commun. 91: 1196-1200, 1979.
17. 2 action on glucose metabolism in cultured fibroblasts. Generation of oxygen-containing free radicals as a mechanism of alloxan action. J. Biol. Chem. 256: 12134-12139, 1981.
18. Juntti-Berggren, L., Lindh, U., Berggren, P.-O. & Frankel, B. J.: Proton microprobe analysis of 15 elements in pancreatic B cells and exocrine pancreas in diabetic Chinese hamsters. Biosci. Rep. 1: 33-41, 1987.
19. Kehrer, J. P. & Lund, L. G.: Cellular reducing equivalents and oxidative stress. Free Radic. Biol. Med. 17: 65-75, 1994.
20. Lagercrantz, C. & Yhland, M.: Free radicals in the reaction of alloxan with glutathione and ascorbic acid. Acta Chem. Scand. 17: 1677-1682, 1963.
21. Lazarow, A.: Alloxan diabetes and the mechanism of beta-cell damage by chemical agents. In: Dealfresnae, J. F. & Smith, G. H. (Eds.): Experimental Diabetes. Blackwell Scientific Publications, Oxford 1954, pp. 49-79.
22. Lenzen, S. & Panten, U.: Alloxan: history and mechanism of action. Diabetologia 31: 337-342, 1988.
23. Lenzen, S., Brand, F.-H. & Panten, U.: Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition. Br. J. Pharmacol. 95: 851-859, 1988.
24. Lenzen, S., Drinkgern, J. & Tiedge, M.: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20: 463-466, 1996.
25. Lloyd, J. B., Cable, H. & Rice-Evans, C.: Evidence that deferoxamine cannot enter cells by passive diffusion. Biochem. Pharmacol. 41: 1361-1363, 1991.
26. Lukens, F. D.: Alloxan diabetes. Physiol. Rev. 28: 304-330, 1948.
27. Malaisse, W. J., Hutton, J. C., Kawazu, S., Herchuelz, A., Valverde, I. & Sener, A.: The stimulus-secretion coupling of glucose-induced insulin release. Diabetologia 16: 331-341, 1979.
28. Malaisse, W. J., Malaisse-Lagae, F., Sener, A. & Pipeleers, D. G.: Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA 79: 927-930, 1982.
29. Malaisse-Lagae, F., Sener, A. & Malaisse, W. J.: Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic B-cell against alloxan. Biochim. Biophys. Acta 762: 36-43, 1983.
30. McDaniel, M. L., Anderson, S., Fink, J. & Roth, C.: Effect of alloxan on permeability and hexose transport in rat pancreatic islets. Endocrinology 97: 68-75, 1975.
31. Ohkuma, S. & Poole, B.: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75: 3327-3331, 1978.
32. Pipeleers, D. & van de Winkel, M.: Pancreatic B cells posses defense mechanisms against cell specific toxicity. Proc. Natl. Acad. Sci. USA 83: 5267-5271, 1986.
33. Rerup, C. C.: Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22: 485-518, 1970.
34. Robbins, E. & Marcus, P. I.: Dynamics of acridine orange-cell interaction. I. Interrelationships of acridine orange particles and cytoplasmic reddening. J. Cell Biol. 18: 237-250, 1963.
35. Rundquist, I., Olsson, M. & Brunk, U.: Cytofluorometric quantitation of acridine orange uptake by cultured cells. Acta path. microbiol. immunol. scand. Sect. A 92: 303-309, 1984.
36. Sagone, A. L. Jr., Greenwald, J., Kraut, E. H., Bianchine, J. & Singh, D.: Glucose: free radical scavenger in biological systems. J. Lab. Clin. Med. 101: 97-104, 1983.
37. Scheynius, A. & Täljedal, I. B.: On the mechanism of glucose protection against alloxan toxicity. Diabetologia 7: 252-255, 1971.
38. Sener, A., Blachier, F. & Malaisse, W. J.: Crabtree effect in tumoral pancreatic islet cells. J. Biol. Chem. 263: 1904-1909, 1988.
39. Starke, P. E., Gilbertson, J. D. & Faber, J. L.: Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem. Biophys. Res. Commun. 133: 371-379, 1985.
40. Tennant, J. R.: Evaluation of the trypan blue technique for determination of cell viability. Transplantation 2: 685-694, 1964.
41. Watkins, D., Cooperstein, S. J. & Lazarow, A.: Effect of alloxan on islet tissue permeability: protection and reversal by sugars. Am. J. Physiol. 3: 718-721, 1973.
42. Weaver, D. C., McDaniel, M. L. & Lacy, P. E.: Alloxan uptake by isolated rat islets of Langerhans. Endocrinology 102: 1847-1855, 1978.
43. Weaver, D. C., McDaniel, M. L., Naber, S. P., Barry, D. & Lacy, P. E.: Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans. Diabetes 27: 1205-1214, 1978.
44. Webb, J. L.: Alloxan. In: Webb, J. L. (Ed.): Enzyme and metabolic inhibitors. Vol III. Academic Press, New York 1966, pp. 367-419.
45. Winterbourn, C. C.: Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82/83: 969-974, 1995.
46. Zawalich, W. S. & Beidler, L. M.: Glucose and alloxan interactions in the pancreatic islets. Am. J. Physiol. 224: 963-966, 1973.
47. Zhang, H. & Brunk, U. T.: Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron - a study on a model system of cultured J-774 cells. Diabetologia 36: 707-715, 1993.
48. Zhang, H., Guixian, G. & Brunk, U. T.: Extracellular reduction of alloxan results in oxygen radical-mediated attack on plasma and lysosomal membranes. APMIS 100: 317-325, 1992.
49. Zhang, H., Olejnicka, B., Öllinger, K. & Brunk, U. T.: Starvation-induced autophagocytosis enhances the susceptibility of insulinoma cells to oxidative stress. Redox Report 2: 235-247, 1996.
50. Zhang, H., Zdolsek, J. M. & Brunk, U. T.: Effects of alloxan and reducing agents on macrophages in culture. APMIS 99: 1038-1048, 1991.
51. Zhang, H., Zdolsek, J. M. & Brunk, U. T.: Alloxan cytotoxicity involves lysosomal damage. APMIS 100: 309-316, 1992.
52. Zhang, H., Öllinger, K. & Brunk, U. T.: Insulinoma cells in culture show pronounced sensitivity to alloxan-induced oxidative stress. Diabetologia 38: 635-641, 1995.